Stockholders’ Equity (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended
	Mar. 06, 2024	Mar. 31, 2024	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Dec. 31, 2023	Oct. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized			20,000,000			20,000,000
Preferred stock, shares issued			0			0
Common stock, shares authorized			100,000,000			100,000,000
Common stock, shares outstanding			1,315,489			534,238
Warrants to purchase							54,174
Exercise of warrants				$ 1,504,339	$ 4,452,163
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from sale of common stock in public offering, shares				344,938	317,259
Warrants to purchase	225,938
Exercise of warrants				$ 345	$ 317
Common Stock [Member] | March Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from sale of common stock in public offering, shares	119,000
Warrants to purchase	119,000
Exercise price	$ 2.43		$ 3.20
Public offering price	$ 2.56
Warrants to purchase			46,875
Prefunded Warrant [Member] | March Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from sale of common stock in public offering, shares	662,251
Exercise price	$ 0.001
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase		137,313	299,000	137,313
Exercise of warrants	225,938	137,313	299,000
Exercise of warrants	$ 1,500,000	$ 137	$ 299
Warrant [Member] | March Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase	662,251
Exercise price	$ 2.43
Public offering price	$ 2.559